Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Key market highlights • Neurovascular diseases: An overview PART 05: Market landscape • Market overview • Five forces analysis PART 06: Market segmentation by product type • Carotid artery stents • Intracranial stents PART 07: Market segmentation by end-user • Hospitals • ASCs PART 08: Geographical segmentation • Neurovascular stents market in Americas • Neurovascular stents market in EMEA • Neurovascular stents market in APAC PART 09: Decision framework PART 10: Drivers and challenges • Market drivers • Impact of drivers on key customer segments • Market challenges • Impact of challenges on key customer segments PART 11: Market trends • Growing research activities coupled with new product launches • Growing focus on the development of biodegradable stents • Growing M&A • Rise in awareness PART 12: Vendor landscape • Competitive scenario • Key news • M&A PART 13: Key vendor analysis • Abbott Laboratories • Medtronic • Stryker • Terumo Medical • Other prominent vendors PART 14: Appendix • List of abbreviations List of Exhibits Exhibit 01: Neurovascular diseases percentage breakdown based on number of cases 2014 Exhibit 02: Neurovascular disease: New techniques and technologies Exhibit 03: Snapshot of global neurovascular stents market Exhibit 04: Global neurovascular stents market: Opportunity analysis Exhibit 05: Global neurovascular stents market 2016-2021 ($ millions) Exhibit 06: Global neurovascular stents market analysis: Developed and emerging markets Exhibit 07: Five forces analysis Exhibit 08: Global neurovascular stents market segmentation by product type 2016 and 2021 (%) Exhibit 09: Global neurovascular stents market segmentation by product type 2016 Exhibit 10: Global neurovascular stents market segmentation by product type 2016: Growth lifecycle analysis Exhibit 11: Global carotid artery stents market 2016-2021 ($ millions) Exhibit 12: Global intracranial stents market 2015-2020 ($ millions) Exhibit 13: Global neurovascular stents market segmentation by product type 2016-2021 ($ millions) Exhibit 14: Global neurovascular stents market segmentation by product type 2016-2021 (%) Exhibit 15: Global neurovascular stents market segmentation by end-user 2016 Exhibit 16: Global neurovascular stents market by geography 2016 and 2021 (%) Exhibit 17: Global neurovascular stents market by geography 2016 Exhibit 18: Global neurovascular stents market by geography 2016: Growth lifecycle analysis Exhibit 19: Neurovascular stents market in Americas: Overview Exhibit 20: Neurovascular stents market in Americas 2016-2021 ($ millions) Exhibit 21: Neurovascular stents market in EMEA: Overview Exhibit 22: Neurovascular stents market in EMEA 2016-2021 ($ millions) Exhibit 23: Neurovascular stents market in APAC: Overview Exhibit 24: Neurovascular stents market in APAC 2016-2021 ($ millions) Exhibit 25: Global neurovascular stents market segmentation by geography 2016-2021 ($ millions) Exhibit 26: Global neurovascular stents market segmentation by geography 2016-2021 (%) Exhibit 27: Some of the nitinol neurovascular stents in the market Exhibit 28: Comparison of nitinol versus stainless steel Exhibit 29: Impact of drivers Exhibit 30: Impact of challenges Exhibit 31: Major M&A Exhibit 32: Competitive structure analysis of global neurovascular stents market 2016 Exhibit 33: Market share of global neurovascular stents market 2016 Exhibit 34: Market penetration of various manufacturers of global neurovascular stents market 2016 Exhibit 35: Strategic success factors of companies in global neurovascular stents market Exhibit 36: Abbott Laboratories: Key highlights Exhibit 37: Abbott Laboratories: Strength assessment Exhibit 38: Abbott Laboratories: Strategy assessment Exhibit 39: Abbott Laboratories: Opportunity assessment Exhibit 40: Medtronic: Key highlights Exhibit 41: Medtronic: Strength assessment Exhibit 42: Medtronic: Strategy assessment Exhibit 43: Medtronic: Opportunity assessment Exhibit 44: Stryker: Key highlights Exhibit 45: Stryker: Strength assessment Exhibit 46: Stryker: Strategy assessment Exhibit 47: Stryker: Opportunity assessment Exhibit 48: Terumo Medical: Key highlights Exhibit 49: Terumo Medical: Strength assessment Exhibit 50: Terumo Medical: Strategy assessment Exhibit 51: Terumo Medical: Opportunity assessment

Abbott Laboratories, Medtronic, Stryker, Terumo Medical, Acandis, Blockade Medical, Codman Neurovascular (Johnson & Johnson), Cordis, Gore Medical, InspireMD, MicroPort Scientific, and STI Laser Industries.